The Myeloma Beacon

Independent, up-to-date news and information for the multiple myeloma community.
Home page Deutsche Artikel Artículos Españoles

Forums

Discussion about multiple myeloma treatments, stem cell transplants, clinical trials, alternative medicines, supplements, and their benefits and side effects.

No Cross-Resistance between Pom and Lenalidamide

by suzierose on Wed Dec 12, 2012 1:59 am

At 2012 ASCO Dr. Vij, presented data showing pomalidomide works in lenalidomide and Bort refractory patients, even those who have failed SCT.

POM, given at 4 mg/day on days 1–21 of each 28-day cycle in combination with LoDEX, 40 mg/week, is effective in pts with RRMM refractory to LEN, BORT, or both, and including those with prior transplant. These results suggest a lack of cross-resistance between POM and LEN, and confirm activity not only in BORT-refractory pts but also those for whom transplant has failed.

http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=114&abstractID=100148

suzierose
Name: suzierose
When were you/they diagnosed?: 2 sept 2011

Re: No Cross-Resistance between Pom and lenalidomide

by Stann on Thu Dec 13, 2012 1:49 pm

excellent news!

Stann


Return to Treatments & Side Effects